A side-by-side comparison of the leading repeal-and-replace proposals.
Oliver Wyman Health
2 min read
Table of Contents
The below infographic shares a side-by-side comparison of the leading repeal-and-replace proposals.
Aledade’s Farzad Mostashari on the Future of Value Transformation Under Trump
Farzad Mostashari weighs in on the future of MSSP and ACOs, and he offers the new administration some health reform advice.
Analysis: Net Premiums Under AHCA
As reported in the WSJ, Oliver Wyman analysis finds some consumers will face higher premiums under AHCA, some much lower. Learn how the replacement plan will impact various markets and consumer segments.
What President-Elect Trump’s Unexpected Win Means for BioPharma
The election results sent biopharma stock soaring. Breaking down what’s really on tap for biopharma over the next four years.
The Election and Healthcare: Your No-Regret Moves
No matter the outcome of the election, here are your no-regret moves.